The Virtual Mentored Implementation to Reduce REVISITS (Reducing Respiratory Emergent Visits using Implementation Science Interventions Tailored to Setting) Study
减少复诊的虚拟指导实施(使用针对环境量身定制的实施科学干预措施减少呼吸系统急诊就诊)研究
基本信息
- 批准号:10171894
- 负责人:
- 金额:$ 78.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:Accident and Emergency departmentAddressAdoptionAdultAffectAmericanCaringChestChicagoChronic Obstructive Airway DiseaseClinicalCohort StudiesCommunicationConsolidated Framework for Implementation ResearchContinuity of Patient CareCost SavingsDataEducationEducational workshopEffectivenessEffectiveness of InterventionsEmergency department visitEnrollmentEvaluationEvidence based interventionEvidence based programFailureGleanGoalsHealth systemHealthcareHospital SocietiesHospitalizationHospitalsHybridsIncentivesIndividualInterventionLeadLeadershipLong-Term CareMediator of activation proteinMedicareMedicineMentorsMethodsModelingNational Heart, Lung, and Blood InstituteOutcomeParticipantPatient CarePatientsPenetrationPersonsPharmaceutical PreparationsPoliciesProgram EffectivenessProgram SustainabilityPublic HealthPublishingRandomizedRecurrenceReportingResourcesSelf ManagementSiteSite VisitSocietiesTrainingUniversitiesVariantVisitacute carebaseburden of illnesscohortcomparative effectivenesscompare effectivenesseffectiveness evaluationeffectiveness implementation designeffectiveness implementation studyevidence baseexperiencehospital readmissionimplementation outcomesimplementation scienceimplementation strategyimprovedinnovationintervention programmortalityprogram costsprogramspulmonary function declinerespiratoryself-management programvirtualvirtual interventionvirtual visit
项目摘要
PROJECT SUMMARY
Chronic Obstructive Pulmonary Disease (COPD) affects 16 million US adults, many of whom experience high
rates of emergency department and hospital COPD revisits after initial hospitalizations due to care transition
failures. These frequent COPD exacerbations lead to more rapid lung function decline and earlier mortality.
Further, hospitalizations for exacerbations highly contribute to the ~$50 billion spent annually for COPD care in
the US. Therefore, COPD revisits are now a public health crisis. It is feasible to improve COPD care and
decrease acute care revisits, as shown by published evidence of successful care transition interventions. Our
team has led efforts to identify effective care transition interventions and has successfully piloted a multi-level
COPD care transition program. Effective care transition interventions include medication reconciliation, self-
management education, and post-discharge communication. However, for wide-spread adoption to occur, we
must identify optimal intervention delivery methods based on hospitals' resources and patient care needs. For
instance, virtually-supported interventions are often more resource-friendly, and while effectiveness data on
individual virtual interventions exists, multi-level virtual programs have not yet been studied compared to in-
person programs. In addition, feasible implementation approaches to support the delivery of evidence-based
care transition programs are needed for wide-scaled dissemination and sustainability. Our team has found that
a mentored implementation model is effective for implementing multi-level, hospital-based programs across US
health systems. This approach traditionally relies on in-person site visits. The use of virtual site visits could
dramatically increase this model's reach, but has not yet been studied. In summary, for successful, wide-scale
adoption, diverse US hospitals need to have access to feasible, multi-level care transition programs and
effective implementation approaches that are aligned with site-specific care needs and resources, but currently
the optimal approach is unknown. Thus, in this proposal, we will compare the effectiveness of virtual vs. in-
person multi-level COPD care transition programs in real-world settings by concurrently studying whether
virtual or in-person mentored implementation increases programs' reach. We will collaborate with the Hospital
Medicine Reengineering Network convened for rapid discovery and dissemination to identify and enroll sites.
After conducting pre-implementation contextual assessments at all sites using the Consolidated Framework for
Implementation Research, we will conduct a Hybrid Type II Effectiveness-Implementation study to determine
effectiveness of the programs to reduce 30-day COPD revisits and of the mentored implementation to increase
program penetration. Finally, we will study programs' sustained outcomes for two years post-implementation.
Data from this study will inform the optimal implementation of COPD care transition programs at scale. Further,
lessons gleaned from this study can inform implementation approaches for other hospital-based programs.
项目总结
慢性阻塞性肺疾病(COPD)影响着1600万美国成年人,其中许多人经历了
急诊科和医院COPD因护理过渡而初次住院后的复诊率
失败。这些频繁的COPD恶化导致更快的肺功能下降和更早的死亡。
此外,因病情恶化而住院极大地贡献了每年用于慢性阻塞性肺病治疗的约500亿美元
美国。因此,慢性阻塞性肺病的复诊现在是一种公共健康危机。改善COPD的护理和治疗是可行的
减少急性护理复诊,已发表的护理过渡干预成功的证据表明。我们的
团队领导了确定有效的护理过渡干预措施的努力,并成功地试行了多层次
慢性阻塞性肺疾病护理过渡计划。有效的护理过渡干预措施包括药物调节、自我
管理教育和出院后沟通。然而,为了实现广泛的采用,我们
必须根据医院的资源和患者的护理需求确定最佳的干预提供方法。为
例如,虚拟支持的干预措施通常对资源更友好,虽然关于
个别虚拟干预措施存在,多层次虚拟方案还没有被研究过。
个人程序。此外,支持提供循证服务的可行执行办法
大范围传播和可持续发展需要护理过渡方案。我们团队发现,
有指导的实施模式对于在全美实施多层次、以医院为基础的项目是有效的
卫生系统。这种方法传统上依赖于面对面的现场访问。使用虚拟站点访问可以
极大地增加了这一模型的覆盖范围,但尚未被研究。总而言之,对于成功的、广泛的
采用,不同的美国医院需要能够获得可行的、多层次的护理过渡计划和
与现场具体护理需求和资源相一致的有效实施方法,但目前
最优的方法是未知的。因此,在这项建议中,我们将比较虚拟与在以下方面的有效性-
在现实世界环境中通过同时研究是否
虚拟或面对面指导的实施扩大了项目的覆盖范围。我们将与医院合作
医学再工程网络召开,以快速发现和传播,以确定和登记地点。
在所有站点使用以下综合框架进行实施前环境评估之后
实施研究,我们将进行第二类混合有效性-实施研究,以确定
减少30天慢性阻塞性肺疾病复诊的方案的有效性和指导实施的有效性
计划渗透率。最后,我们将研究项目实施后两年的持续成果。
这项研究的数据将为大规模COPD护理过渡计划的最佳实施提供信息。此外,
从这项研究中获得的经验教训可以为其他以医院为基础的项目的实施提供参考。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Valerie G Press其他文献
Valerie G Press的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Valerie G Press', 18)}}的其他基金
SMART POR: Supporting and Mentoring Across Respiratory Topics in Patient Oriented Research
SMART POR:支持和指导以患者为导向的研究中的呼吸主题
- 批准号:
10591121 - 财政年份:2023
- 资助金额:
$ 78.67万 - 项目类别:
The Virtual Mentored Implementation to Reduce REVISITS (Reducing Respiratory Emergent Visits using Implementation Science Interventions Tailored to Setting) Study
减少复诊的虚拟指导实施(使用针对环境量身定制的实施科学干预措施减少呼吸系统急诊就诊)研究
- 批准号:
10397608 - 财政年份:2020
- 资助金额:
$ 78.67万 - 项目类别:
The Virtual Mentored Implementation to Reduce REVISITS (Reducing Respiratory Emergent Visits using Implementation Science Interventions Tailored to Setting) Study
减少复诊的虚拟指导实施(使用针对环境量身定制的实施科学干预措施减少呼吸系统急诊就诊)研究
- 批准号:
10609411 - 财政年份:2020
- 资助金额:
$ 78.67万 - 项目类别:
Video vs. TTG Respiratory inhaler technique Assessment and InstructioN (V-TRAIN)
视频与 TTG 呼吸吸入器技术评估和指导 (V-TRAIN)
- 批准号:
8488007 - 财政年份:2013
- 资助金额:
$ 78.67万 - 项目类别:
Video vs. TTG Respiratory inhaler technique Assessment and InstructioN (V-TRAIN)
视频与 TTG 呼吸吸入器技术评估和指导 (V-TRAIN)
- 批准号:
8705006 - 财政年份:2013
- 资助金额:
$ 78.67万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 78.67万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 78.67万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 78.67万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 78.67万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 78.67万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 78.67万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 78.67万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 78.67万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 78.67万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 78.67万 - 项目类别:
Research Grant